Compare AXP & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXP | PFE |
|---|---|---|
| Founded | 1850 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.1B | 155.2B |
| IPO Year | 2004 | 2013 |
| Metric | AXP | PFE |
|---|---|---|
| Price | $300.37 | $26.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 12 |
| Target Price | ★ $336.80 | $27.83 |
| AVG Volume (30 Days) | 3.8M | ★ 31.5M |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | 1.09% | ★ 6.40% |
| EPS Growth | ★ 9.78 | N/A |
| EPS | ★ 15.38 | 1.36 |
| Revenue | $27,819,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $19.24 | N/A |
| Revenue Next Year | $8.82 | N/A |
| P/E Ratio | ★ $19.60 | $19.76 |
| Revenue Growth | ★ 13.44 | N/A |
| 52 Week Low | $220.43 | $20.92 |
| 52 Week High | $387.49 | $27.94 |
| Indicator | AXP | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 32.68 | 47.27 |
| Support Level | $285.32 | $26.29 |
| Resistance Level | $303.79 | $26.74 |
| Average True Range (ATR) | 7.56 | 0.53 |
| MACD | -0.50 | -0.08 |
| Stochastic Oscillator | 15.21 | 28.87 |
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.